Genmab A/S GMAB
$ 20.45
0.0%
Quarterly report 2022-Q2
added 08-10-2022
Country |
Danmark |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Jan G. J. van de Winkel |
Employees in the company |
712 |
Shares |
- |
Market Cap[1] |
$ 13.6 B |
EBITDA (LTM) |
$ 5.56 B |
P/E (LTM) |
0.57 |
P/S (LTM) |
2.72 |
EPS (LTM) |
62.2 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.